Jul 2026
Abstract B017: CLD-401, a Systemic Gene Medicine for In Situ IL-15 Superagonist Delivery: Driving NK and γδ T Cell-Mediated Tumor Killing
These findings support IND submission (CLD-401) by end of 2026 and clinical trial initiation in H1 2027, positioning RedTail as a next-generation gene medicine platform.
Yunyi Kang, D. Nguyen, S. Songco et al.
· Clinical Cancer Research · 0 citations